Split Cas9, not hairs: advancing the therapeutic index of CRISPR technology

The discovery that the bacterial CRISPR/Cas9 system can be translated into mammalian cells continues to have an unprecedented impact on the biomedical research community, as it largely facilitates efforts to experimentally interrogate or therapeutically modify the cellular genome. In particular, CRI...

Full description

Saved in:
Bibliographic Details
Main Authors: Schmelas, Carolin (Author) , Grimm, Dirk (Author)
Format: Article (Journal)
Language:English
Published: 05 January 2018
In: Biotechnology journal
Year: 2018, Volume: 13, Issue: 9
ISSN:1860-7314
DOI:10.1002/biot.201700432
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/biot.201700432
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/biot.201700432
Get full text
Author Notes:Carolin Schmelas, Dirk Grimm

MARC

LEADER 00000caa a2200000 c 4500
001 1693357410
003 DE-627
005 20230427033641.0
007 cr uuu---uuuuu
008 200326s2018 xx |||||o 00| ||eng c
024 7 |a 10.1002/biot.201700432  |2 doi 
035 |a (DE-627)1693357410 
035 |a (DE-599)KXP1693357410 
035 |a (OCoLC)1341311064 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schmelas, Carolin  |d 1990-  |e VerfasserIn  |0 (DE-588)1172687900  |0 (DE-627)1041321996  |0 (DE-576)514737603  |4 aut 
245 1 0 |a Split Cas9, not hairs  |b advancing the therapeutic index of CRISPR technology  |c Carolin Schmelas, Dirk Grimm 
264 1 |c 05 January 2018 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published: 05 January 2018 
500 |a Gesehen am 26.03.2020 
520 |a The discovery that the bacterial CRISPR/Cas9 system can be translated into mammalian cells continues to have an unprecedented impact on the biomedical research community, as it largely facilitates efforts to experimentally interrogate or therapeutically modify the cellular genome. In particular, CRISPR promises the ability to correct disease-associated genetic defects, or to target and destroy invading foreign DNA, in a simple, efficient, and selective manner directly in affected human cells or tissues. Here, we highlight a set of exciting new strategies that aim at further increasing the therapeutic index of CRISPR technologies, by reducing the size of Cas9 expression cassettes and thus enhancing their compatibility with viral gene delivery vectors. Specifically, we discuss the concept of splitCas9 whereby the Cas9 holo-protein is segregated into two parts that are expressed individually and reunited in the cell by various means, including use of 1) the gRNA as a scaffold for Cas9 assembly; 2) the rapamycin-controlled FKBP/FRB system; 3) the light-regulated Magnet system; or 4) inteins. We describe how these avenues, despite pursuing the identical aim, differ in critical features comprising the extent of spatio-temporal control of CRISPR activity, and discuss additional improvements to their efficiency or specificity that should foster their clinical translation. 
650 4 |a AAV 
650 4 |a Cas9 
650 4 |a CRISPR 
650 4 |a inteins 
650 4 |a splitCas9 
700 1 |a Grimm, Dirk  |e VerfasserIn  |0 (DE-588)1016476671  |0 (DE-627)70553376X  |0 (DE-576)352260645  |4 aut 
773 0 8 |i Enthalten in  |t Biotechnology journal  |d Weinheim : Wiley-VCH, 2006  |g 13 (2018,9) Artikel-Nummer 1700432, 12 Seiten  |h Online-Ressource  |w (DE-627)504861972  |w (DE-600)2214038-4  |w (DE-576)254168604  |x 1860-7314  |7 nnas  |a Split Cas9, not hairs advancing the therapeutic index of CRISPR technology 
773 1 8 |g volume:13  |g year:2018  |g number:9  |g extent:12  |a Split Cas9, not hairs advancing the therapeutic index of CRISPR technology 
856 4 0 |u https://doi.org/10.1002/biot.201700432  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/biot.201700432  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200326 
993 |a Article 
994 |a 2018 
998 |g 1016476671  |a Grimm, Dirk  |m 1016476671:Grimm, Dirk  |d 910000  |d 911700  |e 910000PG1016476671  |e 911700PG1016476671  |k 0/910000/  |k 1/910000/911700/  |p 2  |y j 
998 |g 1172687900  |a Schmelas, Carolin  |m 1172687900:Schmelas, Carolin  |d 910000  |d 911700  |e 910000PS1172687900  |e 911700PS1172687900  |k 0/910000/  |k 1/910000/911700/  |p 1  |x j 
999 |a KXP-PPN1693357410  |e 3613901404 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Carolin Schmelas, Dirk Grimm"]},"title":[{"subtitle":"advancing the therapeutic index of CRISPR technology","title_sort":"Split Cas9, not hairs","title":"Split Cas9, not hairs"}],"recId":"1693357410","relHost":[{"pubHistory":["1.2006 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"part":{"year":"2018","extent":"12","volume":"13","issue":"9","text":"13 (2018,9) Artikel-Nummer 1700432, 12 Seiten"},"disp":"Split Cas9, not hairs advancing the therapeutic index of CRISPR technologyBiotechnology journal","title":[{"title_sort":"Biotechnology journal","subtitle":"systems & synthetic biology, nanobiotech, medicine","title":"Biotechnology journal"}],"recId":"504861972","id":{"zdb":["2214038-4"],"issn":["1860-7314"],"eki":["504861972"],"doi":["10.1002/(ISSN)1860-7314"]},"titleAlt":[{"title":"BTJ"}],"origin":[{"publisherPlace":"Weinheim","publisher":"Wiley-VCH","dateIssuedDisp":"[2006]-"}],"note":["Gesehen am 5. November 2022"],"physDesc":[{"extent":"Online-Ressource"}]}],"id":{"doi":["10.1002/biot.201700432"],"eki":["1693357410"]},"origin":[{"dateIssuedDisp":"05 January 2018","dateIssuedKey":"2018"}],"person":[{"family":"Schmelas","roleDisplay":"VerfasserIn","given":"Carolin","role":"aut","display":"Schmelas, Carolin"},{"family":"Grimm","roleDisplay":"VerfasserIn","role":"aut","display":"Grimm, Dirk","given":"Dirk"}],"note":["First published: 05 January 2018","Gesehen am 26.03.2020"],"physDesc":[{"extent":"12 S."}]} 
SRT |a SCHMELASCASPLITCAS9N0520